ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1372

Characterization of Synovial Mast Cells in Knee Osteoarthritis: Association with Clinical Parameters

Badelog J.E. de Lange-Brokaar1, Margreet Kloppenburg1, Stefan Andersen1, Annemarie Dorjee1, Erlangga Yusuf1, Linda van Toorn1, Herman Kroon2, Anne-Marie Zuurmond3, Vedrana Stojanovic-Susulic4, Johan Bloem2, Rob Nelissen5, René E. M. Toes6 and Andreea Ioan-Facsinay1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Radiology, Leiden University Medical Center, Leiden, Netherlands, 3TNO, Leiden, Netherlands, 4Janssen, Pharmaceutical Companies Johnson & Johnson, Springhouse, PA, 5Orthopaedics, Leiden University Medical Center, Leiden, Netherlands, 6Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Inflammation, mast cells and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Innate Immunity and Rheumatic Disease Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Synovial inflammation is a common feature of osteoarthritis (OA) and rheumatoid arthritis (RA) patients. Comparative studies indicated that synovitis, measured by histology or imaging, is more severe in RA than in OA, which is also reflected in more infiltrating immune cells in RA than in OA. Intriguingly, mast cell numbers were found in some studies to be equal or lower in RA than OA. Here, we wished to expand these findings using immunofluorescence  and to assess the possible relevance of mast cells in OA by studying  their association with clinical parameters, such as radiographic damage and pain.    

Methods: Synovial tissues of 56 symptomatic OA and 49 RA patients were obtained from arthroscopy (early disease) (22 OA, 23 RA) or arthroplasty (late disease) (34 OA, 26 RA). Two to three paraffin slides were used to quantify inflammation using haematoxylin and eosin staining (synovitis score 0-9), and to quantify and determine degranulation state of mast cells (per 10 high-power fields) using double immunofluorescence for CD117 and tryptase. Average scores per patient were used for analysis. Knee radiographs of OA patients were scored according to the Kellgren and Lawrence (KL) system and self-reported pain was determined in OA patients by visual analogue scale at baseline.

Results:

Median (range) of mast cells was significantly higher in OA samples 45 (1-168) compared to RA samples 4 (1-47) (p-value < 0.001), despite a lower median (range) synovitis score in OA (2.5 (0-6.0)) compared to 4.6 (0-8.0) in RA samples. This held true when comparing the subgroups of early and late samples between diagnoses. Similar percentages of mast cells were degranulated in both diseases at all stages, indicating that the abundance of these cells rather than degranulation state could be relevant for the disease process. The synovitis score correlated with the number of mast cells both in OA (Spearman’s rho = 0.3, p =0.023) and RA (Spearman’s rho = 0.5,p < 0.001), indicating that mast cells could contribute to synovial inflammation in both diseases, although their contribution is probably moderate. Interestingly, the number of mast cells was associated with an increased KL-grade (p-value 0.05) in OA patients, independently of synovitis. No associations were found with self-reported pain. 

Conclusion:

Prevalence of mast cells in OA synovial tissue is higher than in RA. Interestingly, it appears to be associated with synovial inflammation, as well as structural damage in OA patients, suggesting a role of mast cells in this disease.


Disclosure: B. J. E. de Lange-Brokaar, None; M. Kloppenburg, TI-Pharma, Centocor, 2; S. Andersen, None; A. Dorjee, None; E. Yusuf, None; L. van Toorn, None; H. Kroon, None; A. M. Zuurmond, None; V. Stojanovic-Susulic, Janssen RD, 1,Janssen Pharmaceutica Product, L.P., 3; J. Bloem, None; R. Nelissen, Dutch Arthritis Foundation, Zon-MW, 2; R. E. M. Toes, None; A. Ioan-Facsinay, EULAR, Dutch Arthritis Foundation, 2.

To cite this abstract in AMA style:

de Lange-Brokaar BJE, Kloppenburg M, Andersen S, Dorjee A, Yusuf E, van Toorn L, Kroon H, Zuurmond AM, Stojanovic-Susulic V, Bloem J, Nelissen R, Toes REM, Ioan-Facsinay A. Characterization of Synovial Mast Cells in Knee Osteoarthritis: Association with Clinical Parameters [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/characterization-of-synovial-mast-cells-in-knee-osteoarthritis-association-with-clinical-parameters/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterization-of-synovial-mast-cells-in-knee-osteoarthritis-association-with-clinical-parameters/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology